Seraph Pharmaceutical products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Pharmaceutical manufacturer · Islamabad · Pakistan
Islamabad-based pharmaceutical manufacturer producing general and cephalosporin dosage forms including tablets, capsules, topicals and injectables.
Seraph Pharmaceutical products in Pakistan
Seraph Pharmaceutical has 102 medicine presentations registered in Pakistan under 39 brands, covering 35 generic medicines. Most of its products are in Anti-infectives, CNS & mental health and Dermatology. Its brands with the most registered strengths and packs are Droncef (Ceftriaxone), Levace (Levetiracetam), Oris (Risperidone) and Cequel (Quetiapine). 102 products have an official DRAP price on MedInfoBase. See all 39 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Company type
- Pharmaceutical manufacturer
- Address
- Plot No. 210, Industrial Triangle, Kahuta Road, Islamabad, Pakistan
- Website
- seraphpharmaceutical.com ↗
- Phone
- +92 51 4493210
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 88%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Seraph Pharmaceutical is priced against the market
95 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Actarin | Miconazole | 20 mg/g | Gel | 20 gm | 103748 | PKR 135.54 | PKR 6.78/g | 🔒 Pharma Pro |
| Anbrez | Anastrozole | 1 mg | Tablet | 3x10's | 093358 | PKR 9,901.11 | PKR 330.04/tablet | 🔒 Pharma Pro |
| Azikem | Azithromycin | 250 mg | Tablet | 1x6's | 094387 | PKR 269.05 | PKR 44.84/tablet | 🔒 Pharma Pro |
| Azikem | Azithromycin | 500 mg | Tablet | 1x6's | 094388 | PKR 493.26 | PKR 82.21/tablet | 🔒 Pharma Pro |
| Azipar | Azithromycin | 250 mg | Capsule | 1x6's | 093357 | PKR 274.43 | PKR 45.74/capsule | 🔒 Pharma Pro |
| Azipar | Azithromycin | 250 mg | Capsule | 1x10's | 093357 | PKR 435.05 | PKR 43.51/capsule | 🔒 Pharma Pro |
| Camvitra 20mg TabletRegistry verified | Vardenafil hydrochloride | — | — | — | 134131Official source ↗ | No indexed price | — | — |
| Canzo | Fluconazole | 150 mg | Capsule | 1's | 087364 | PKR 247.53 | PKR 247.53/capsule | 🔒 Pharma Pro |
| Cartrial | Calcipotriol | 0.05 mg | Cream | 15 gm | 092340 | PKR 658.94 | PKR 43.93/g | No comparator |
| Cartrial | Calcipotriol | 0.005% | Cream | 5 gm | 092340 | PKR 220.27 | PKR 44.05/g | 🔒 Pharma Pro |
| Cartrial | Calcipotriol | 0.05 mg/g | Cream | 60 gm | 092340 | PKR 2,503.93 | PKR 41.73/g | No comparator |
| Cartrial | Calcipotriol | 0.005% | Cream | 30 gm | 092340 | PKR 1,344.22 | PKR 44.81/g | 🔒 Pharma Pro |
| Cartrial Plus | Calcipotriol + Betamethasone | 0.05 mg + 0.5 mg | Ointment | 15 gm | 092341 | PKR 706.00 | PKR 47.07/g | No comparator |
| Cequel | Quetiapine | 25 mg | Tablet | 3x10's | 085273 | PKR 626.57 | PKR 20.89/tablet | 🔒 Pharma Pro |
| Cequel | Quetiapine | 25 mg | Tablet | 1x10's | 085273 | PKR 208.86 | PKR 20.89/tablet | 🔒 Pharma Pro |
| Cequel | Quetiapine | 25 mg | Tablet | 2x10's | 085273 | PKR 417.70 | PKR 20.89/tablet | 🔒 Pharma Pro |
| Cequel | Quetiapine | 100 mg | Tablet | 1x10's | 085274 | PKR 626.57 | PKR 62.66/tablet | 🔒 Pharma Pro |
| Cequel | Quetiapine | 300 mg | Tablet | 1x10's | 094149 | PKR 1,253.11 | PKR 125.31/tablet | 🔒 Pharma Pro |
| Cequel 150mg XR | Quetiapine | 150 mg | Extended-release tablet | 1x10's | 094385 | PKR 812.43 | PKR 81.24/tablet | 🔒 Pharma Pro |
| Cerapime Injection IM/IV 1gRegistry verified | Cefepime (as hydrochloride) (with L-arginine) | — | — | — | 092119Official source ↗ | No indexed price | — | — |
| Cerapime Injection IM/IV 500mgRegistry verified | Cefepime (as hydrochloride) (with L-arginine) | — | — | — | 092118Official source ↗ | No indexed price | — | — |
| Certum | Ceftazidime | 250 mg | Injection | 1's | 086237 | PKR 148.36 | PKR 148.36/vial/unit | 🔒 Pharma Pro |
| Certum | Ceftazidime | 500 mg | Injection | 1's | 086238 | PKR 213.64 | PKR 213.64/vial/unit | 🔒 Pharma Pro |
| Certum | Ceftazidime | 1 g | Injection | 1's | 086239 | PKR 407.97 | PKR 407.97/vial/unit | 🔒 Pharma Pro |
| Certum Plus 2/5gRegistry verified | Avibactam as Sodium, Ceftazidime as Pentahydrate | — | — | — | 135404Official source ↗ | No indexed price | — | — |
| Ciptec | Ciprofloxacin | 250 mg | Tablet | 1x10's | 093355 | PKR 233.17 | PKR 23.32/tablet | 🔒 Pharma Pro |
| Ciptec | Ciprofloxacin | 500 mg | Tablet | 1x10's | 093356 | PKR 385.64 | PKR 38.56/tablet | 🔒 Pharma Pro |
| Czartan | Losartan | 50 mg | Tablet | 2x10's | 094150 | PKR 358.73 | PKR 17.94/tablet | 🔒 Pharma Pro |
| Czartan Plus 50/12.5mg | Losartan + Hydrochlorothiazide | 50 mg + 12.5 mg | Tablet | 2x10's | 094137 | PKR 538.10 | PKR 26.91/tablet | 🔒 Pharma Pro |
| DSource observed | Cholecalciferol | 5 mg/1 mL | Injection | 1's | 103718Official source ↗ | No indexed price | — | — |
| DSource observed | Cholecalciferol | 5 mg/1 mL | Injection | 5's | 103718Official source ↗ | No indexed price | — | — |
| DSource observed | Cholecalciferol | 5 mg/1 mL | Injection | 1's | 103718Official source ↗ | No indexed price | — | — |
| Dexsero XR 45mg/105mg TabletRegistry verified | Bupropion Hydrochloride, Dextromethorphan Hydrobromide | — | — | — | 126606Official source ↗ | No indexed price | — | — |
| Droncef | Ceftriaxone | 250 mg | IM injection | 1's | 087745 | PKR 181.16 | PKR 181.16/vial/unit | 🔒 Pharma Pro |
| Droncef | Ceftriaxone | 500 mg | IM injection | 1's | 087746 | PKR 304.92 | PKR 304.92/vial/unit | 🔒 Pharma Pro |
| Droncef | Ceftriaxone | 1 g | Injection | 25's | 087747 | PKR 13,559.04 | PKR 542.36/vial/unit | 🔒 Pharma Pro |
| Droncef | Ceftriaxone | 1 g | Injection | 1's | 087747 | PKR 575.77 | PKR 575.77/vial/unit | 🔒 Pharma Pro |
| Droncef | Ceftriaxone | 1 g | Injection | 10's | 087747 | PKR 5,423.83 | PKR 542.38/vial/unit | 🔒 Pharma Pro |
| Droncef | Ceftriaxone | 2 g | Injection | 25's | 087748 | PKR 19,362.72 | PKR 774.51/vial/unit | 🔒 Pharma Pro |
| Droncef | Ceftriaxone | 2 g | Injection | 1's | 087748 | PKR 807.15 | PKR 807.15/vial/unit | 🔒 Pharma Pro |
| Droncef | Ceftriaxone | 2 g | Injection | 10's | 087748 | PKR 7,744.66 | PKR 774.47/vial/unit | 🔒 Pharma Pro |
| Droncef | Ceftriaxone | 500 mg | IV injection | 25's | 103746 | PKR 6,497.04 | PKR 259.88/vial/unit | 🔒 Pharma Pro |
| Droncef | Ceftriaxone | 500 mg | IV injection | 1's | 103746 | PKR 271.06 | PKR 271.06/vial/unit | 🔒 Pharma Pro |
| Droncef | Ceftriaxone | 500 mg | IV injection | 10's | 103746 | PKR 2,597.96 | PKR 259.80/vial/unit | 🔒 Pharma Pro |
| Droncef | Ceftriaxone | 250 mg | IV injection | 1's | 103747 | PKR 161.04 | PKR 161.04/vial/unit | 🔒 Pharma Pro |
| Empro 40mg InjectionRegistry verified | Esomeprazole as sodium | — | — | — | 110932Official source ↗ | No indexed price | — | — |
| Empro-N 375/20mg TabletRegistry verified | Esomeprazole as Magnesium Trihydrate, Naproxen | — | — | — | 138494Official source ↗ | No indexed price | — | — |
| Empro-N 500/20mg TabletRegistry verified | Esomeprazole as Magnesium Trihydrate, Naproxen | — | — | — | 138495Official source ↗ | No indexed price | — | — |
| Eniqa | Eflornithine | 11.5% | Cream | 15 gm | 092349 | PKR 1,835.60 | PKR 122.37/g | No comparator |
| Fascar | Clarithromycin | 250 mg | Tablet | 1x10's | 094145 | PKR 430.48 | PKR 43.05/tablet | 🔒 Pharma Pro |
All 39 Seraph Pharmaceutical brands in Pakistan
- Actarin Miconazole · 20 mg/g gel
- Anbrez Anastrozole · 1 mg tablet
- Azikem Azithromycin · 250 mg tablet, 500 mg tablet
- Azipar Azithromycin · 250 mg capsule
- Canzo Fluconazole · 150 mg capsule
- Cartrial Calcipotriol · 0.005% cream, 0.05 mg cream, 0.05 mg/g cream
- Cartrial Plus Calcipotriol + Betamethasone · 0.05 mg + 0.5 mg ointment
- Cequel Quetiapine · 100 mg tablet, 25 mg tablet, 300 mg tablet
- Cequel 150mg XR Quetiapine · 150 mg tablet
- Certum Ceftazidime · 1 g injection, 250 mg injection, 500 mg injection
- Ciptec Ciprofloxacin · 250 mg tablet, 500 mg tablet
- Czartan Losartan · 50 mg tablet
- Czartan Plus 50/12.5mg Losartan + Hydrochlorothiazide · 50 mg + 12.5 mg tablet
- Droncef Ceftriaxone · 1 g injection, 2 g injection, 250 mg injection
- Eniqa Eflornithine · 11.5% cream
- Fascar Clarithromycin · 250 mg tablet, 500 mg tablet
- Fascar XL Fascar XL Clarithromycin · 500 mg tablet
- Furoxim Cefuroxime · 250 mg injection
- Icunem Meropenem · 1 g injection, 500 mg injection
- Kefone Cefazolin · 1 g injection, 250 mg injection, 500 mg injection
- Klindaseph Clindamycin · 10 mg gel
- Lamoraf Lamotrigine = · 100 mg tablet, 50 mg tablet
- Levace Levetiracetam · 100 mg/mL injection, 100 mg/mL solution, 250 mg tablet
- Lexus Levofloxacin · 250 mg tablet, 500 mg tablet, 750 mg tablet
- Lizobact Linezolid · 100 mg/5 mL suspension, 2 mg/mL infusion, 600 mg tablet
- Meraz Omeprazole enteric coated pellets, Omeprazole · 20 mg capsule, 40 mg injection, 40 mg capsule
- Moxer Moxifloxacin · 400 mg tablet
- Oris Risperidone · 1 mg tablet, 2 mg tablet, 3 mg tablet
- Pernit Permethrin · 5 % lotion
- Sebifin Terbinafine · 1% w/w cream, 125 mg tablet, 250 mg tablet
- Selet Letrozole · 2.5 mg tablet
- Sephide Potassium iodide · 130 mg tablet
- Sephrix B Entecavir · 0.5 mg tablet
- Serquin Hydroxychloroquine · 200 mg tablet
- Sthrin Permethrin · 5% cream
- Tefotaxime Cefotaxime · 1 g injection, 250 mg injection, 500 mg injection
- Trispan Cefixime · 200 mg capsule
- Zyban Bupropion · 300 mg tablet
- Zyban 150mg SR Bupropion · 150 mg tablet
Seraph Pharmaceutical: common questions
How many products does Seraph Pharmaceutical have in Pakistan?
Seraph Pharmaceutical has 102 registered medicine presentations in Pakistan, sold under 39 brands and covering 35 generic medicines.
What are the main brands of Seraph Pharmaceutical?
By number of registered strengths and packs, its largest brands are Droncef (Ceftriaxone), Levace (Levetiracetam), Oris (Risperidone), Cequel (Quetiapine) and Meraz (Omeprazole enteric coated pellets, Omeprazole). This is not a sales ranking.
Which therapy areas does Seraph Pharmaceutical cover?
The most products are in Anti-infectives (57), CNS & mental health (28), Dermatology (5), Gastrointestinal & hepatology (5) and Oncology & immunology (4).
Where can I see Seraph Pharmaceutical medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.